| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.85e-06 | 18 | 241 | 5 | GO:0008569 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCC3 VWA8 ABCA13 MCM5 DHX9 LONP1 ABCC8 HFM1 DNAH8 DYNC1H1 PIF1 MOV10 DDX51 CHD7 DDX55 DNAH7 POLQ SNRNP200 DNAH11 | 1.88e-06 | 441 | 241 | 19 | GO:0016887 |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 4.94e-06 | 37 | 241 | 6 | GO:0045505 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCC3 VWA8 ABCA13 MYO10 MCM5 DHX9 LONP1 ABCC8 HFM1 DNAH8 DYNC1H1 PIF1 MOV10 DDX51 CHD7 DDX55 DNAH7 DNAH1 POLQ SNRNP200 DNAH11 | 1.91e-05 | 614 | 241 | 21 | GO:0140657 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.92e-05 | 28 | 241 | 5 | GO:0051959 | |
| GeneOntologyMolecularFunction | helicase activity | 2.28e-05 | 158 | 241 | 10 | GO:0004386 | |
| GeneOntologyMolecularFunction | type I interferon receptor binding | 4.35e-05 | 17 | 241 | 4 | GO:0005132 | |
| GeneOntologyMolecularFunction | single-stranded DNA helicase activity | 1.53e-04 | 23 | 241 | 4 | GO:0017116 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ABCC3 VWA8 ABCA13 MCM5 DHX9 LONP1 ABCC8 HFM1 DNAH8 DYNC1H1 PIF1 MOV10 DDX51 CHD7 DDX55 RAB6B DNAH7 RGS20 POLQ SNRNP200 ENTPD8 DNAH11 | 1.88e-04 | 775 | 241 | 22 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ABCC3 VWA8 ABCA13 MCM5 DHX9 LONP1 ABCC8 HFM1 DNAH8 DYNC1H1 PIF1 MOV10 DDX51 CHD7 DDX55 RAB6B DNAH7 PLPP6 RGS20 POLQ SNRNP200 ENTPD8 DNAH11 | 2.22e-04 | 839 | 241 | 23 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ABCC3 VWA8 ABCA13 MCM5 DHX9 LONP1 ABCC8 HFM1 DNAH8 DYNC1H1 PIF1 MOV10 DDX51 CHD7 DDX55 RAB6B DNAH7 PLPP6 RGS20 POLQ SNRNP200 ENTPD8 DNAH11 | 2.26e-04 | 840 | 241 | 23 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ABCC3 VWA8 ABCA13 MCM5 DHX9 LONP1 ABCC8 HFM1 DNAH8 DYNC1H1 PIF1 MOV10 DDX51 CHD7 DDX55 RAB6B DNAH7 PLPP6 RGS20 POLQ SNRNP200 ENTPD8 DNAH11 | 2.26e-04 | 840 | 241 | 23 | GO:0016818 |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on RNA | 4.14e-04 | 80 | 241 | 6 | GO:0008186 | |
| GeneOntologyMolecularFunction | mediator complex binding | 8.57e-04 | 4 | 241 | 2 | GO:0036033 | |
| GeneOntologyMolecularFunction | DNA/RNA helicase activity | 8.57e-04 | 4 | 241 | 2 | GO:0033677 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | MCM5 DHX9 CNOT6 POP1 HFM1 POLK NIPBL FDXACB1 PIF1 MOV10 DDX51 CHD7 DDX55 DTD2 CNOT6L TFB1M POLQ SNRNP200 | 8.82e-04 | 645 | 241 | 18 | GO:0140640 |
| GeneOntologyMolecularFunction | DNA helicase activity | 9.08e-04 | 62 | 241 | 5 | GO:0003678 | |
| GeneOntologyMolecularFunction | DNA replication origin binding | 1.24e-03 | 18 | 241 | 3 | GO:0003688 | |
| GeneOntologyBiologicalProcess | cellular response to virus | 9.89e-06 | 90 | 239 | 8 | GO:0098586 | |
| Domain | ARM-type_fold | DCAF1 STK36 STAG1 FOCAD CLTC UTP20 NIPBL TANGO6 ZYG11A RTTN USP24 APC NBEA FRYL MEI1 WDFY4 CSE1L WDFY3 SYMPK | 1.00e-07 | 339 | 242 | 19 | IPR016024 |
| Domain | - | PODNL1 FBXL13 TMOD4 LRRC4 RSU1 BGN CNOT6 PXDNL NXF5 LMOD1 LRRN2 ZYG11A PRAMEF19 NLRX1 PRAMEF18 ADGRA2 NLRP6 CNOT6L | 2.18e-07 | 321 | 242 | 18 | 3.80.10.10 |
| Domain | L_dom-like | PODNL1 FBXL13 TMOD4 LRRC4 RSU1 BGN CNOT6 PXDNL NXF5 LMOD1 LRRN2 ZYG11A PRAMEF19 NLRX1 PRAMEF18 ADGRA2 NLRP6 CNOT6L | 3.00e-07 | 328 | 242 | 18 | IPR032675 |
| Domain | ARM-like | DCAF1 STK36 STAG1 UTP20 NIPBL TANGO6 ZYG11A RTTN APC NBEA FRYL MEI1 WDFY4 CSE1L WDFY3 SYMPK | 5.03e-07 | 270 | 242 | 16 | IPR011989 |
| Domain | ATPase_dyneun-rel_AAA | 6.38e-07 | 14 | 242 | 5 | IPR011704 | |
| Domain | MT | 6.38e-07 | 14 | 242 | 5 | PF12777 | |
| Domain | AAA_8 | 6.38e-07 | 14 | 242 | 5 | PF12780 | |
| Domain | AAA_5 | 6.38e-07 | 14 | 242 | 5 | PF07728 | |
| Domain | Dynein_heavy_chain_D4_dom | 6.38e-07 | 14 | 242 | 5 | IPR024317 | |
| Domain | Dynein_HC_stalk | 6.38e-07 | 14 | 242 | 5 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 6.38e-07 | 14 | 242 | 5 | IPR013602 | |
| Domain | DHC_N2 | 6.38e-07 | 14 | 242 | 5 | PF08393 | |
| Domain | DHC_fam | 9.47e-07 | 15 | 242 | 5 | IPR026983 | |
| Domain | Dynein_heavy | 9.47e-07 | 15 | 242 | 5 | PF03028 | |
| Domain | Dynein_heavy_dom | 9.47e-07 | 15 | 242 | 5 | IPR004273 | |
| Domain | - | ABCC3 VWA8 ABCA13 MCM5 SLFN5 DHX9 LONP1 TRANK1 ABCC8 HS3ST6 HFM1 DNAH8 DYNC1H1 CARD14 PIF1 MOV10 DDX51 CHD7 DDX55 RAB6B DNAH7 DNAH1 ORC5 POLQ SNRNP200 DNAH11 | 4.72e-06 | 746 | 242 | 26 | 3.40.50.300 |
| Domain | P-loop_NTPase | ABCC3 VWA8 ABCA13 MYO10 MCM5 SLFN5 DHX9 LONP1 TRANK1 ABCC8 HS3ST6 HFM1 DNAH8 DYNC1H1 CARD14 PIF1 MOV10 DDX51 CHD7 DDX55 RAB6B DNAH7 DNAH1 NLRP6 ORC5 POLQ SNRNP200 DNAH11 | 5.54e-06 | 848 | 242 | 28 | IPR027417 |
| Domain | - | DCAF1 STK36 UTP20 NIPBL TANGO6 ZYG11A RTTN APC FRYL WDFY4 CSE1L WDFY3 SYMPK | 6.86e-06 | 222 | 242 | 13 | 1.25.10.10 |
| Domain | AAA+_ATPase | ABCC3 VWA8 ABCA13 LONP1 ABCC8 DNAH8 DYNC1H1 DNAH7 SNRNP200 DNAH11 | 1.86e-05 | 144 | 242 | 10 | IPR003593 |
| Domain | AAA | ABCC3 VWA8 ABCA13 LONP1 ABCC8 DNAH8 DYNC1H1 DNAH7 SNRNP200 DNAH11 | 1.86e-05 | 144 | 242 | 10 | SM00382 |
| Domain | Interferon | 5.73e-05 | 17 | 242 | 4 | PF00143 | |
| Domain | INTERFERON_A_B_D | 5.73e-05 | 17 | 242 | 4 | PS00252 | |
| Domain | Interferon_alpha/beta/delta | 5.73e-05 | 17 | 242 | 4 | IPR000471 | |
| Domain | IFabd | 5.73e-05 | 17 | 242 | 4 | SM00076 | |
| Domain | PH_BEACH | 1.15e-04 | 8 | 242 | 3 | PS51783 | |
| Domain | DHC_N1 | 1.15e-04 | 8 | 242 | 3 | PF08385 | |
| Domain | PH-BEACH_dom | 1.15e-04 | 8 | 242 | 3 | IPR023362 | |
| Domain | - | 1.15e-04 | 8 | 242 | 3 | 2.30.29.40 | |
| Domain | Dynein_heavy_dom-1 | 1.15e-04 | 8 | 242 | 3 | IPR013594 | |
| Domain | BEACH | 1.70e-04 | 9 | 242 | 3 | PS50197 | |
| Domain | Beach | 1.70e-04 | 9 | 242 | 3 | SM01026 | |
| Domain | BEACH_dom | 1.70e-04 | 9 | 242 | 3 | IPR000409 | |
| Domain | Beach | 1.70e-04 | 9 | 242 | 3 | PF02138 | |
| Domain | - | 1.70e-04 | 9 | 242 | 3 | 1.10.1540.10 | |
| Domain | Leu-rich_rpt | PODNL1 FBXL13 LRRC4 RSU1 BGN CNOT6 PXDNL NXF5 LRRN2 NLRX1 ADGRA2 CNOT6L | 2.28e-04 | 271 | 242 | 12 | IPR001611 |
| Domain | UBA | 2.52e-04 | 44 | 242 | 5 | IPR015940 | |
| Domain | LRR | 3.02e-04 | 201 | 242 | 10 | PS51450 | |
| Domain | UBA | 3.45e-04 | 47 | 242 | 5 | PS50030 | |
| Domain | DEAD/DEAH_box_helicase_dom | 3.67e-04 | 73 | 242 | 6 | IPR011545 | |
| Domain | DEAD | 3.67e-04 | 73 | 242 | 6 | PF00270 | |
| Domain | LRR_8 | 4.00e-04 | 171 | 242 | 9 | PF13855 | |
| Domain | Helicase_C | 4.88e-04 | 107 | 242 | 7 | PF00271 | |
| Domain | HELICc | 4.88e-04 | 107 | 242 | 7 | SM00490 | |
| Domain | Glyco_hydro_15/PHK | 4.97e-04 | 3 | 242 | 2 | IPR011613 | |
| Domain | Dipep_AS | 4.97e-04 | 3 | 242 | 2 | IPR000180 | |
| Domain | Glyco_hydro_15 | 4.97e-04 | 3 | 242 | 2 | PF00723 | |
| Domain | RENAL_DIPEPTIDASE_2 | 4.97e-04 | 3 | 242 | 2 | PS51365 | |
| Domain | Renal_dipep_fam | 4.97e-04 | 3 | 242 | 2 | IPR008257 | |
| Domain | Peptidase_M19 | 4.97e-04 | 3 | 242 | 2 | PF01244 | |
| Domain | PHK_A/B_su | 4.97e-04 | 3 | 242 | 2 | IPR008734 | |
| Domain | RENAL_DIPEPTIDASE_1 | 4.97e-04 | 3 | 242 | 2 | PS00869 | |
| Domain | Leu-rich_rpt_typical-subtyp | 5.15e-04 | 177 | 242 | 9 | IPR003591 | |
| Domain | LRR_TYP | 5.15e-04 | 177 | 242 | 9 | SM00369 | |
| Domain | Helicase_C | 5.16e-04 | 108 | 242 | 7 | IPR001650 | |
| Domain | DEXDc | 5.46e-04 | 109 | 242 | 7 | SM00487 | |
| Domain | HELICASE_CTER | 5.46e-04 | 109 | 242 | 7 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 5.46e-04 | 109 | 242 | 7 | PS51192 | |
| Domain | Helicase_ATP-bd | 5.77e-04 | 110 | 242 | 7 | IPR014001 | |
| Domain | LRR_1 | PODNL1 FBXL13 LRRC4 RSU1 BGN CNOT6 PXDNL LRRN2 ADGRA2 CNOT6L | 5.94e-04 | 219 | 242 | 10 | PF00560 |
| Domain | Sec63 | 9.86e-04 | 4 | 242 | 2 | PF02889 | |
| Domain | Sec63 | 9.86e-04 | 4 | 242 | 2 | SM00973 | |
| Domain | Sec63-dom | 9.86e-04 | 4 | 242 | 2 | IPR004179 | |
| Domain | UBA | 1.17e-03 | 36 | 242 | 4 | PF00627 | |
| Domain | UBA-like | 1.43e-03 | 64 | 242 | 5 | IPR009060 | |
| Domain | DUF4704 | 1.63e-03 | 5 | 242 | 2 | IPR031570 | |
| Domain | DUF4704 | 1.63e-03 | 5 | 242 | 2 | PF15787 | |
| Domain | Semaphorin | 2.08e-03 | 20 | 242 | 3 | IPR027231 | |
| Domain | PH_BEACH | 2.42e-03 | 6 | 242 | 2 | PF14844 | |
| Domain | LON | 2.42e-03 | 6 | 242 | 2 | SM00464 | |
| Domain | LON_N | 2.42e-03 | 6 | 242 | 2 | PS51787 | |
| Domain | PIP49_C | 2.42e-03 | 6 | 242 | 2 | PF12260 | |
| Domain | LON_substr-bd_dom | 2.42e-03 | 6 | 242 | 2 | IPR003111 | |
| Domain | LON_substr_bdg | 2.42e-03 | 6 | 242 | 2 | PF02190 | |
| Domain | PEROXIDASE_1 | 2.42e-03 | 6 | 242 | 2 | PS00435 | |
| Domain | Ribosomal_S6_kinase_II | 2.42e-03 | 6 | 242 | 2 | IPR016239 | |
| Domain | FAM69_kinase_dom | 2.42e-03 | 6 | 242 | 2 | IPR022049 | |
| Pathway | REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING | 3.83e-07 | 23 | 184 | 6 | MM15634 | |
| Pathway | REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING | 8.45e-07 | 26 | 184 | 6 | M982 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IFN_RIPK1_3_SIGNALING_PATHWAY | 2.56e-06 | 31 | 184 | 6 | M47964 | |
| Pathway | BIOCARTA_IFNA_PATHWAY | 3.60e-06 | 19 | 184 | 5 | MM1571 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 4.52e-06 | 34 | 184 | 6 | MM15631 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_II_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY | 6.16e-06 | 21 | 184 | 5 | M47909 | |
| Pathway | WP_INTERFERONMEDIATED_SIGNALING | 7.57e-06 | 37 | 184 | 6 | M39785 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_I_IFN_SIGNALING_PATHWAY | 9.98e-06 | 23 | 184 | 5 | M47452 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_I_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY | 1.25e-05 | 24 | 184 | 5 | M47908 | |
| Pathway | REACTOME_RSV_HOST_INTERACTIONS | 4.18e-05 | 98 | 184 | 8 | M48247 | |
| Pathway | WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY | 4.63e-05 | 31 | 184 | 5 | M39897 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_TAT_TO_TLR2_4_NFKB_SIGNALING_PATHWAY | 5.85e-05 | 17 | 184 | 4 | M47564 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CGAS_STING_SIGNALING_PATHWAY | 7.45e-05 | 18 | 184 | 4 | M47539 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 8.17e-05 | 138 | 184 | 9 | MM15635 | |
| Pathway | REACTOME_EVASION_BY_RSV_OF_HOST_INTERFERON_RESPONSES | 8.48e-05 | 35 | 184 | 5 | M48246 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF7_SIGNALING_PATHWAY | 9.34e-05 | 19 | 184 | 4 | M47450 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR7_9_IRF7_SIGNALING_PATHWAY | 1.16e-04 | 20 | 184 | 4 | M47617 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR7_8_9_IRF5_SIGNALING_PATHWAY | 1.71e-04 | 22 | 184 | 4 | M47897 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RIG_I_NFKB_SIGNALING_PATHWAY | 1.71e-04 | 22 | 184 | 4 | M47616 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY | 1.75e-04 | 120 | 184 | 8 | M48233 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MDA5_IRF7_3_SIGNALING_PATHWAY | 2.43e-04 | 24 | 184 | 4 | M47782 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RIG_I_IRF7_3_SIGNALING_PATHWAY | 2.43e-04 | 24 | 184 | 4 | M47576 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 3.90e-04 | 27 | 184 | 4 | M47755 | |
| Pathway | BIOCARTA_CYTOKINE_PATHWAY | 4.50e-04 | 28 | 184 | 4 | MM1378 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 5.37e-04 | 78 | 184 | 6 | M973 | |
| Pathway | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | 5.90e-04 | 30 | 184 | 4 | M936 | |
| Pathway | WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION | 7.16e-04 | 14 | 184 | 3 | M39772 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ABCC3 STK36 NR2F6 ACACA VWA8 MYO10 ANKRD9 RPS6KA2 MED14 MCM5 SPPL2B CNTROB TYK2 FOCAD FASN KCNH2 CD2BP2 WDR90 HERC2 DYNC1H1 PLOD3 SEMA7A NLRX1 RTTN LAMA5 FRYL MED13L ADGRA2 C6orf132 TTLL4 OGDHL WDFY3 CEP170B SYMPK | 8.71e-13 | 1105 | 248 | 34 | 35748872 |
| Pubmed | ACACA MCM5 ACTN1 URB2 GTF3C3 LONP1 FASN FAM120A POP1 CLTC UTP20 HERC2 NIPBL DYNC1H1 MOV10 AHCTF1 USP24 DDX51 FRYL CHD7 CSE1L NAT10 NUP93 SNRNP200 SYMPK | 1.18e-11 | 653 | 248 | 25 | 22586326 | |
| Pubmed | PRPF31 ACTR5 MED14 MCM5 ACTN1 URB2 SIX4 NDUFS8 SEMA4C CNOT6 KIDINS220 INTS2 POP1 UTP20 HERC2 NIPBL MOV10 SLC25A24 PLOD3 AHCTF1 APC LAMA5 DDX51 CHD7 DDX55 RAB6B CYFIP2 PLPP6 C6orf132 ORC5 COL18A1 INTS6 CNOT6L TFB1M MED25 CEP170B | 1.87e-10 | 1497 | 248 | 36 | 31527615 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | DCAF1 PRPF31 STAG1 GTF3C3 B4GALT1 DHX9 CNOT6 PHKB FASN FAM120A WASHC5 CD2BP2 FECH POP1 CLTC BUB1B HERC2 NIPBL DYNC1H1 MOV10 MPO CWC15 AHCTF1 DTL APC ORC5 CNOT6L NUP93 RPA3 SNRNP200 CEP170B | 2.85e-10 | 1155 | 248 | 31 | 20360068 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DCAF1 PRPF31 ACACA MCM5 ACTN1 URB2 MIDEAS GTF3C3 DHX9 LONP1 FASN FAM120A WASHC5 POP1 CLTC AP1M1 UTP20 HERC2 NIPBL DYNC1H1 MOV10 MPO AHCTF1 DDX51 CHD7 CSE1L TFB1M NAT10 NUP93 WDFY3 SNRNP200 | 1.19e-08 | 1353 | 248 | 31 | 29467282 |
| Pubmed | GALNT1 CENPN DIPK1A INPP5B RPS6KA3 SPPL2B PHKB INTS2 FECH POP1 CLTC POLK PRAMEF19 AHCTF1 DTL APC FRYL CHD7 CUBN ANKRD50 PRAMEF18 WDFY4 COL18A1 CNOT6L TTLL4 NAT10 OGDHL | 2.07e-08 | 1084 | 248 | 27 | 11544199 | |
| Pubmed | 3.36e-08 | 14 | 248 | 5 | 9373155 | ||
| Pubmed | DCAF1 MBTPS1 ZNF536 TSPOAP1 MYO10 URB2 NEDD4 FOCAD KIDINS220 CLTC CLEC16A DYNC1H1 NEDD4L TTC28 MED13L CEP170B | 4.67e-08 | 407 | 248 | 16 | 12693553 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | STAG1 MCM5 DHX9 FASN HSPA12A BUB1B NIPBL DYNC1H1 CWC15 USP24 CHD7 ORC5 INTS6 CSE1L NAT10 NUP93 SNRNP200 CDK3 SYMPK | 4.84e-08 | 582 | 248 | 19 | 20467437 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MBTPS1 ACACA INPP4A RPS6KA2 SPPL2B RSU1 B4GALT1 TYK2 PHKB EXD3 KIDINS220 FAM120A NDRG1 INTS2 ABCC8 FECH POLK CLEC16A RPS6KL1 NEDD4L FRYL SRCIN1 RAB6B DNAH1 COL18A1 INTS6 TLL1 NAT10 TTC21B ECHDC2 CEP170B | 1.02e-07 | 1489 | 248 | 31 | 28611215 |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | DCAF1 ZNF765 ZNF813 ACTN1 SLFN5 URB2 KMT2E GTF3C3 B4GALT1 DHX9 FASN LMF2 INTS2 WASHC5 GLI3 CLTC ZNF468 C6orf89 AHCTF1 CYFIP2 ORC5 ZNF28 CSE1L ZNF525 NUP93 SNRNP200 SYMPK | 1.69e-07 | 1203 | 248 | 27 | 29180619 |
| Pubmed | TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B. | 2.52e-07 | 20 | 248 | 5 | 11694501 | |
| Pubmed | MCM5 DHX9 HSPA12A HFM1 HERC2 MOV10 DTL APC LAMA5 DDX55 NUP93 POLQ | 2.82e-07 | 250 | 248 | 12 | 33536335 | |
| Pubmed | 3.58e-07 | 3 | 248 | 3 | 26823285 | ||
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | STAG1 MYO10 SPPL2B NEDD4 CNOT6 NIPBL NEDD4L FRYL CHD7 MED13L PPAT INTS6 SIDT2 TTLL4 WDFY3 ECHDC2 SYMPK | 3.75e-07 | 536 | 248 | 17 | 15840001 |
| Pubmed | STAG1 MYO10 SPPL2B NEDD4 CNOT6 NIPBL NEDD4L FRYL CHD7 MED13L PPAT INTS6 SIDT2 TTLL4 WDFY3 ECHDC2 SYMPK | 3.95e-07 | 538 | 248 | 17 | 10512203 | |
| Pubmed | GAK INPP4A ACTN1 CADM2 NDUFS8 DHX9 PHKB LONP1 FASN HSPA12A KIDINS220 FAM120A WASHC5 CLTC DYNC1H1 CPEB2 VPS18 KRT16 NEDD4L APC NBEA SRCIN1 CYFIP2 CSE1L OGDHL SNRNP200 CEP170B SCAI DNAH11 | 4.75e-07 | 1431 | 248 | 29 | 37142655 | |
| Pubmed | PRPF31 STAG1 GTF3C3 FASN INTS2 CD2BP2 CLTC NIPBL DYNC1H1 MED13L NAT10 SNRNP200 | 6.92e-07 | 272 | 248 | 12 | 31010829 | |
| Pubmed | 8.01e-07 | 11 | 248 | 4 | 18835032 | ||
| Pubmed | High-affinity binding of 125I-labelled mouse interferon to a specific cell surface receptor. | 8.01e-07 | 11 | 248 | 4 | 6444699 | |
| Pubmed | Structural and functional neuropathology in transgenic mice with CNS expression of IFN-alpha. | 8.01e-07 | 11 | 248 | 4 | 10448195 | |
| Pubmed | IFN-alpha can both protect against and promote the development of type 1 diabetes. | 8.01e-07 | 11 | 248 | 4 | 19120292 | |
| Pubmed | Effect of interferon-alpha on immediate early gene expression of murine cytomegalovirus. | 8.01e-07 | 11 | 248 | 4 | 8389790 | |
| Pubmed | The mouse IFN-alpha (Ifa) locus: correlation of physical and linkage maps by in situ hybridization. | 8.01e-07 | 11 | 248 | 4 | 3456887 | |
| Pubmed | Mechanism of SUMOylation-Mediated Regulation of Type I IFN Expression. | 8.01e-07 | 11 | 248 | 4 | 36681180 | |
| Pubmed | Type I interferon dependence of plasmacytoid dendritic cell activation and migration. | 8.01e-07 | 11 | 248 | 4 | 15795237 | |
| Pubmed | 8.01e-07 | 11 | 248 | 4 | 9794439 | ||
| Pubmed | 8.01e-07 | 11 | 248 | 4 | 25310498 | ||
| Pubmed | ACACA INPP5B GTF3C3 DHX9 SEMA4C KIDINS220 GLI3 CLTC RHBDD3 CLEC16A SDK1 DYNC1H1 KRT16 TTC28 APC NBEA ANKRD50 DNAH7 CRB1 SNRNP200 | 9.33e-07 | 777 | 248 | 20 | 35844135 | |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | DCAF1 PRPF31 GTF3C3 DHX9 PHKA1 PHKB LONP1 FAM120A FECH BUB1B HERC2 MOV10 APC GRPR COL18A1 SNRNP200 CDK3 SYMPK | 9.37e-07 | 639 | 248 | 18 | 23443559 |
| Pubmed | GAK GALNT1 MED14 MCM5 B4GALT1 DHX9 CNOT6 LONP1 FASN LMF2 KIDINS220 FAM120A INTS2 CLTC AP1M1 HERC2 DYNC1H1 DDX51 DDX55 CYFIP2 CSE1L LRP10 NAT10 CD74 NUP93 | 1.18e-06 | 1168 | 248 | 25 | 19946888 | |
| Pubmed | 1.19e-06 | 12 | 248 | 4 | 16565497 | ||
| Pubmed | Regulation of effector and memory T-cell functions by type I interferon. | 1.19e-06 | 12 | 248 | 4 | 21320124 | |
| Pubmed | MAVS Deficiency Is Associated With a Reduced T Cell Response Upon Secondary RSV Infection in Mice. | 1.19e-06 | 12 | 248 | 4 | 33123150 | |
| Pubmed | A novel anti-viral role for STAT3 in IFN-α signalling responses. | 1.19e-06 | 12 | 248 | 4 | 27988795 | |
| Pubmed | Evolution of the interferon alpha gene family in eutherian mammals. | 1.19e-06 | 12 | 248 | 4 | 17512142 | |
| Pubmed | 1.19e-06 | 12 | 248 | 4 | 9425112 | ||
| Pubmed | 1.19e-06 | 12 | 248 | 4 | 8656058 | ||
| Pubmed | Repression of the murine interferon alpha 11 gene: identification of negatively acting sequences. | 1.19e-06 | 12 | 248 | 4 | 1886773 | |
| Pubmed | The physical separation of Lps and Ifa loci in BXH recombinant inbred mice. | 1.19e-06 | 12 | 248 | 4 | 2572648 | |
| Pubmed | Developmental control of IFN-alpha expression in murine embryos. | 1.19e-06 | 12 | 248 | 4 | 7925651 | |
| Pubmed | The role of type 1 interferons in coagulation induced by gram-negative bacteria. | 1.19e-06 | 12 | 248 | 4 | 32016282 | |
| Pubmed | Multiple pathways of interferon-induced gene expression in murine macrophages. | 1.19e-06 | 12 | 248 | 4 | 7684767 | |
| Pubmed | 1.19e-06 | 12 | 248 | 4 | 6188104 | ||
| Pubmed | Ligation of CD180 inhibits IFN-α signaling in a Lyn-PI3K-BTK-dependent manner in B cells. | 1.19e-06 | 12 | 248 | 4 | 26277892 | |
| Pubmed | 1.19e-06 | 12 | 248 | 4 | 6689487 | ||
| Pubmed | Interferon-alpha initiates type 1 diabetes in nonobese diabetic mice. | 1.19e-06 | 12 | 248 | 4 | 18716002 | |
| Pubmed | Negative regulation of the alpha interferon-induced antiviral response by the Ras/Raf/MEK pathway. | 1.19e-06 | 12 | 248 | 4 | 16611902 | |
| Pubmed | 1.19e-06 | 12 | 248 | 4 | 30967261 | ||
| Pubmed | Interferon-alpha subtype 11 activates NK cells and enables control of retroviral infection. | 1.19e-06 | 12 | 248 | 4 | 22912583 | |
| Pubmed | 1.19e-06 | 12 | 248 | 4 | 23747509 | ||
| Pubmed | 1.19e-06 | 12 | 248 | 4 | 17434974 | ||
| Pubmed | 1.19e-06 | 12 | 248 | 4 | 18937499 | ||
| Pubmed | Structure and expression of a new murine interferon-alpha gene: MuIFN-alpha I9. | 1.19e-06 | 12 | 248 | 4 | 3758677 | |
| Pubmed | 1.19e-06 | 12 | 248 | 4 | 19406830 | ||
| Pubmed | 1.19e-06 | 12 | 248 | 4 | 8245849 | ||
| Pubmed | 1.19e-06 | 12 | 248 | 4 | 22685550 | ||
| Pubmed | 1.19e-06 | 12 | 248 | 4 | 3017340 | ||
| Pubmed | 1.19e-06 | 12 | 248 | 4 | 20038206 | ||
| Pubmed | Murine alpha/beta interferons inhibit benzo(a)pyrene activation and mutagenesis in mice. | 1.19e-06 | 12 | 248 | 4 | 8304945 | |
| Pubmed | 1.19e-06 | 12 | 248 | 4 | 11846978 | ||
| Pubmed | Identification of distal silencing elements in the murine interferon-A11 gene promoter. | 1.19e-06 | 12 | 248 | 4 | 8760352 | |
| Pubmed | Behavioral effects of mouse interferons-alpha and -gamma and human interferon-alpha in mice. | 1.19e-06 | 12 | 248 | 4 | 1422836 | |
| Pubmed | Role of interferons in the regulation of cell proliferation, differentiation, and development. | 1.19e-06 | 12 | 248 | 4 | 7530016 | |
| Pubmed | 1.19e-06 | 12 | 248 | 4 | 17277125 | ||
| Pubmed | 1.19e-06 | 12 | 248 | 4 | 9794206 | ||
| Pubmed | Isolation and mapping of four new DNA markers from mouse chromosome 4. | 1.19e-06 | 12 | 248 | 4 | 1360280 | |
| Pubmed | 1.19e-06 | 12 | 248 | 4 | 17451966 | ||
| Pubmed | 1.19e-06 | 12 | 248 | 4 | 25897172 | ||
| Pubmed | A polymorphic trinucleotide repeat sequence mapping to distal mouse chromosome 4. | 1.19e-06 | 12 | 248 | 4 | 8672140 | |
| Pubmed | 1.19e-06 | 12 | 248 | 4 | 7601556 | ||
| Pubmed | Decoding type I and III interferon signalling during viral infection. | 1.26e-06 | 27 | 248 | 5 | 30936491 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | ACTN1 BGN B4GALT1 SLC22A6 FASN HSPA12A NDRG1 UBAC1 CLTC AP1M1 NIPBL ALK DYNC1H1 MPO COL6A3 PLOD3 AHCTF1 LAMA5 CUBN SLC22A12 CYFIP2 COL18A1 CSE1L | 1.26e-06 | 1016 | 248 | 23 | 19056867 |
| Pubmed | p90RSK2 is essential for FLT3-ITD- but dispensable for BCR-ABL-induced myeloid leukemia. | 1.43e-06 | 4 | 248 | 3 | 21527514 | |
| Pubmed | Nedd4-2-dependent ubiquitylation and regulation of the cardiac potassium channel hERG1. | 1.43e-06 | 4 | 248 | 3 | 21463633 | |
| Pubmed | Characterization of interferon-alpha 13, a novel constitutive murine interferon-alpha subtype. | 1.72e-06 | 13 | 248 | 4 | 12930842 | |
| Pubmed | Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. | 1.72e-06 | 13 | 248 | 4 | 2014240 | |
| Pubmed | 1.72e-06 | 13 | 248 | 4 | 18005734 | ||
| Pubmed | 1.72e-06 | 13 | 248 | 4 | 12050368 | ||
| Pubmed | Isolation and bacterial expression of a murine alpha leukocyte interferon gene. | 1.72e-06 | 13 | 248 | 4 | 6094686 | |
| Pubmed | 1.72e-06 | 13 | 248 | 4 | 2993652 | ||
| Pubmed | 1.72e-06 | 13 | 248 | 4 | 1655578 | ||
| Pubmed | 1.72e-06 | 13 | 248 | 4 | 2471809 | ||
| Pubmed | 1.72e-06 | 13 | 248 | 4 | 21263073 | ||
| Pubmed | 1.72e-06 | 13 | 248 | 4 | 8438572 | ||
| Pubmed | 1.72e-06 | 13 | 248 | 4 | 38660315 | ||
| Pubmed | 1.72e-06 | 13 | 248 | 4 | 9343822 | ||
| Pubmed | Evidence for a different susceptibility of primate lentiviruses to type I interferons. | 1.72e-06 | 13 | 248 | 4 | 23255800 | |
| Pubmed | 1.72e-06 | 13 | 248 | 4 | 7523540 | ||
| Pubmed | 1.72e-06 | 13 | 248 | 4 | 7510216 | ||
| Pubmed | 1.72e-06 | 13 | 248 | 4 | 19635904 | ||
| Pubmed | 1.72e-06 | 13 | 248 | 4 | 19706714 | ||
| Pubmed | 1.72e-06 | 13 | 248 | 4 | 23804712 | ||
| Pubmed | 1.72e-06 | 13 | 248 | 4 | 22431588 | ||
| Pubmed | Mouse interferon alpha and beta genes are linked at the centromere proximal region of chromosome 4. | 1.72e-06 | 13 | 248 | 4 | 3973562 | |
| Pubmed | Organization, structure and expression of murine interferon alpha genes. | 1.72e-06 | 13 | 248 | 4 | 2987810 | |
| Pubmed | 1.72e-06 | 13 | 248 | 4 | 19130550 | ||
| Pubmed | 1.72e-06 | 13 | 248 | 4 | 21469099 | ||
| Pubmed | 1.72e-06 | 13 | 248 | 4 | 22739040 | ||
| Pubmed | 1.72e-06 | 13 | 248 | 4 | 20065291 | ||
| Interaction | TOP3B interactions | ABCC3 STK36 NR2F6 ACACA VWA8 MYO10 ANKRD9 RPS6KA2 MED14 MCM5 ACTN1 SPPL2B CNTROB DHX9 TYK2 FOCAD LONP1 FASN FAM120A KCNH2 CD2BP2 WDR90 HERC2 DYNC1H1 MOV10 PLOD3 SEMA7A NLRX1 RTTN LAMA5 FRYL MED13L ADGRA2 C6orf132 CNOT6L TTLL4 OGDHL WDFY3 RPA3 CEP170B SYMPK | 2.73e-07 | 1470 | 240 | 41 | int:TOP3B |
| Interaction | SIRT7 interactions | DCAF1 ACACA MCM5 ACTN1 URB2 GTF3C3 LONP1 FASN FAM120A POP1 CLTC UTP20 HERC2 NIPBL DYNC1H1 MOV10 AHCTF1 USP24 DDX51 FRYL CHD7 CSE1L NAT10 NUP93 SNRNP200 SYMPK | 9.73e-07 | 744 | 240 | 26 | int:SIRT7 |
| Cytoband | 9p22 | 9.77e-06 | 25 | 249 | 4 | 9p22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9p21 | 6.27e-05 | 124 | 249 | 6 | chr9p21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q15 | 1.60e-04 | 147 | 249 | 6 | chr15q15 | |
| GeneFamily | Dyneins, axonemal | 1.67e-05 | 17 | 171 | 4 | 536 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 6.70e-05 | 9 | 171 | 3 | 1230 | |
| GeneFamily | Interferons | 2.26e-04 | 32 | 171 | 4 | 598 | |
| GeneFamily | Immunoglobulin like domain containing|Semaphorins | 8.42e-04 | 20 | 171 | 3 | 736 | |
| Coexpression | GSE23398_WT_VS_IL2_KO_CD4_TCELL_SCURFY_MOUSE_UP | INPP5B ANKRD9 RPS6KA2 MCM5 INTS2 C3 DDX51 CSE1L CD74 LONRF3 ECHDC2 | 3.22e-06 | 199 | 247 | 11 | M8080 |
| Coexpression | GSE10273_HIGH_VS_LOW_IL7_TREATED_IRF4_8_NULL_PRE_BCELL_DN | NAB2 TMCC3 KIDINS220 HERC2 VAV1 DYNC1H1 SEC16B TTC28 USP24 CHD7 PLPP6 | 3.22e-06 | 199 | 247 | 11 | M316 |
| Coexpression | SHIN_B_CELL_LYMPHOMA_CLUSTER_5 | 7.04e-06 | 29 | 247 | 5 | MM586 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | GALNT1 STAG1 MYO10 RPS6KA2 RPS6KA3 NEDD4 KIDINS220 BUB1B UTP20 CLEC16A NIPBL SLC25A24 TRIM2 TTC28 AHCTF1 USP24 APC FRYL MED13L ORC5 RGS20 CSE1L WDFY3 | 7.17e-06 | 856 | 247 | 23 | M4500 |
| Coexpression | KASLER_HDAC7_TARGETS_1_UP | ANKRD9 PGLYRP2 B4GALT1 PHKA1 FASN AP1M1 FRYL CYFIP2 LRP10 UBASH3B | 1.52e-05 | 192 | 247 | 10 | M2317 |
| Coexpression | KASLER_HDAC7_TARGETS_1_UP | ANKRD9 PGLYRP2 B4GALT1 PHKA1 FASN AP1M1 FRYL CYFIP2 LRP10 UBASH3B | 1.66e-05 | 194 | 247 | 10 | MM910 |
| Coexpression | GSE41867_NAIVE_VS_DAY6_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN | 2.16e-05 | 200 | 247 | 10 | M9496 | |
| Coexpression | MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP | MYO10 URB2 DHX9 LONP1 INTS2 POP1 NIPBL TANGO6 TRIM2 DDX51 MEI1 PPAT INTS6 SCAI | 3.67e-05 | 408 | 247 | 14 | M11891 |
| Coexpression | GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_3H_IFNG_STIM_UP | 4.29e-05 | 174 | 247 | 9 | M6296 | |
| Coexpression | MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP | MYO10 URB2 DHX9 LONP1 INTS2 POP1 NIPBL TANGO6 TRIM2 DDX51 MEI1 PPAT INTS6 SCAI | 4.41e-05 | 415 | 247 | 14 | MM1028 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | TSPOAP1 INPP4A KMT2E CADM2 HSPA12A GFOD1 CPEB2 LRP12 TRIM2 NEDD4L APC LAMA5 NBEA GRIK3 SRCIN1 MED13L CYFIP2 ZNF28 CNOT6L WDR97 NPFF TLL1 OGDHL UBASH3B SCAI | 5.16e-05 | 1106 | 247 | 25 | M39071 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | STK36 ABCA13 CADM2 FREM2 TRANK1 TRPM3 SDK1 CACNA1F GRIK3 DNAH1 DNAH11 | 7.79e-09 | 184 | 249 | 11 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | STK36 ABCA13 CADM2 FREM2 TRANK1 TRPM3 SDK1 CACNA1F GRIK3 DNAH1 DNAH11 | 7.79e-09 | 184 | 249 | 11 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | STK36 ABCA13 CADM2 FREM2 TRANK1 TRPM3 SDK1 CACNA1F GRIK3 DNAH1 DNAH11 | 7.79e-09 | 184 | 249 | 11 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | (08)_PNEC-(1)_24hpi|(08)_PNEC / shred by cell type and Timepoint | 1.16e-08 | 29 | 249 | 6 | f1b59a0b6bce5772bfb084f08507cf775e7eae8c | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYO10 RPS6KA2 FAM120A ABCC8 CLTC DYNC1H1 TTC28 NBEA FRYL CYFIP2 | 1.59e-07 | 195 | 249 | 10 | 7796ea9247f4c63762f0de8490fed08b9717fa23 |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.48e-07 | 156 | 249 | 9 | af47a4b17342bdb3cb62d7e2d52a81168e588629 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.24e-07 | 161 | 249 | 9 | b81b346309f3facbfbebd91cae4c5b33c7bd24ef | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.59e-07 | 163 | 249 | 9 | 8028636632c168dc50731d0ebecaf88a70daf81d | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_DC-DC-DC1|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.87e-07 | 169 | 249 | 9 | 488ba50631a64cb9e0d69219491c66ac824c9e7d | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.49e-07 | 183 | 249 | 9 | 42dc31d587fbb9724b2f0be5ee8ed77233f67b86 | |
| ToppCell | COVID-CD4-CD8_1|COVID / Condition, Cell_class and T cell subcluster | 1.04e-06 | 185 | 249 | 9 | c634bb04a081ae3214b68f6e4a147db5b2b916ed | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.41e-06 | 192 | 249 | 9 | d6f656be2698bd215717d35f4e7ab727c08c61e0 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-Pericytes|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.41e-06 | 192 | 249 | 9 | 7aadc7c5bd03274f9861dde2febda5c37f8afc9c | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-06 | 195 | 249 | 9 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | SPPL2B LRRC4 HSPA12A WDR90 CFAP47 C1orf87 SRCIN1 DNAH7 DNAH11 | 1.75e-06 | 197 | 249 | 9 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 |
| ToppCell | Children_(3_yrs)-Immune-dendritic_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.32e-06 | 152 | 249 | 8 | 0769857f25da2e6169420818e61d65e33b7277b1 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Lymphocytic|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.67e-06 | 167 | 249 | 8 | 3d5a6a4c7d037b1a6a8ec90034d88ef6d256e843 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Lymphocytic-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.67e-06 | 167 | 249 | 8 | 41675d15919104c9e20cd97620fe636f3ff33fa9 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.10e-06 | 169 | 249 | 8 | c135d7ae0490d0024e0f4bd8c4ad42f6674a61da | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-06 | 171 | 249 | 8 | 913bae728b5e653771a27c79a309eb023699f1d0 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-06 | 171 | 249 | 8 | f28b2336057e353b96a6ff4581ec9fd0ca0789d9 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.80e-06 | 172 | 249 | 8 | bc3ed05fdd94d5e1f19285aea867b1453292baec | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Endothelial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.32e-06 | 174 | 249 | 8 | c58328c2f262506a4518f49f148e29874faf9171 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.32e-06 | 174 | 249 | 8 | 6c36d607c48267a75ab4da6fb2fe3f931d1b3b52 | |
| ToppCell | Adult-Immune-dendritic_cell-D175|Adult / Lineage, Cell type, age group and donor | 6.87e-06 | 176 | 249 | 8 | 1f0f1f953e6d61119f342de0d980aa1287511dba | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.87e-06 | 176 | 249 | 8 | 3bbac5c2397535631fce8fa98f6ddb4fe0260351 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.43e-06 | 181 | 249 | 8 | 5a4fe0eca7cbc9cbc8a2fdbe795a7c5f4052a659 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 8.78e-06 | 182 | 249 | 8 | b54ae650c04dfd0759c5f5e752b9bf684dd36516 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 9.89e-06 | 185 | 249 | 8 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l33-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.89e-06 | 185 | 249 | 8 | 47c69500877b851c0c9744f5e1ef2ee0bff99168 | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 9.89e-06 | 185 | 249 | 8 | 636505a3d96f75d951ab42bcf8af6ae07abc732d | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 1.03e-05 | 186 | 249 | 8 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-05 | 187 | 249 | 8 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | droplet-Thymus-nan-18m-Myeloid-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-05 | 187 | 249 | 8 | ed69e7cbd6fb59363b0e26f24887fc49405397ce | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-05 | 187 | 249 | 8 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-Pericytes-Pericyte|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.20e-05 | 190 | 249 | 8 | 136ca6da77a202874376af193a1dd71d810c76c4 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-05 | 190 | 249 | 8 | 562ee3b025c29edf07b8b344323edb49d82f1c7e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-05 | 190 | 249 | 8 | f5fb989afabb49d64d91324570cd8c80a4b9e67d | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.30e-05 | 192 | 249 | 8 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.34e-05 | 193 | 249 | 8 | d5930f7bd9b299f792212d40a3272a37adf64a82 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.34e-05 | 193 | 249 | 8 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.34e-05 | 193 | 249 | 8 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.40e-05 | 194 | 249 | 8 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.40e-05 | 194 | 249 | 8 | e5990880961d2469759ce4b3b20ae93ace3ebd1f | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.50e-05 | 196 | 249 | 8 | b8b9801181d7604871b48aebacb295d0a57a5eaf | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.62e-05 | 198 | 249 | 8 | 5fc25b008a4d8d6bec83923a16f64dd9e1ff1f2d | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.62e-05 | 198 | 249 | 8 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.68e-05 | 199 | 249 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.68e-05 | 199 | 249 | 8 | b10698aee2e6c17bc559eb4f723024141f914b90 | |
| ToppCell | TCGA-Stomach-Primary_Tumor|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.68e-05 | 199 | 249 | 8 | 38f1f612b29feb868322999ceeda78e52447ec4f | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.74e-05 | 200 | 249 | 8 | ca5401b76ab014080914bf78042d368cf318effa | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.74e-05 | 200 | 249 | 8 | d2fcd3bd7c3223875f027eeb48ff621192a5f242 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1--L2-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.74e-05 | 200 | 249 | 8 | 70c47d3bbe67d88c5b9dff99c33a603d25fa2ab0 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.74e-05 | 200 | 249 | 8 | 40286010bd17cf9e34ecd5440953b072ebfae208 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.74e-05 | 200 | 249 | 8 | 786f1ae53e60b5ffbf4bfd393d10b802478148b3 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Stem_cells-Neuroepithelial_cell|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 1.74e-05 | 200 | 249 | 8 | c9479452ab8c51139522383f745f02171ebbd7e2 | |
| ToppCell | distal-mesenchymal-Pericyte|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.74e-05 | 200 | 249 | 8 | fe31287cfb51d45643bdedbaa5efc03ed87263c6 | |
| ToppCell | Non-neuronal-Dividing-IPC|World / Primary Cells by Cluster | 1.74e-05 | 200 | 249 | 8 | 971533181daa1bfac1f1b8c507d2013f891f9078 | |
| ToppCell | distal-mesenchymal-Pericyte-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.74e-05 | 200 | 249 | 8 | 867935701fac71a3fe01578362da0676f959736c | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Stem_cells|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 1.74e-05 | 200 | 249 | 8 | 0bba93f1271dac704dddcdea8cb0f84a7ac6f42a | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-cDC2-cDC2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.01e-05 | 148 | 249 | 7 | 3f48f5ba0a0928ddf6da7a1be1976933921f42ad | |
| ToppCell | PND07-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.71e-05 | 155 | 249 | 7 | b5d5c38b269e9318970fcce564df1c8ed7a7ccc6 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.94e-05 | 157 | 249 | 7 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | 368C-Myeloid-Dendritic-cDC_activated|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.32e-05 | 160 | 249 | 7 | bcd90ef96464bd901b87b94c696de70c113bfd03 | |
| ToppCell | droplet-Heart-nan-24m-Hematologic-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-05 | 161 | 249 | 7 | 7e60001637ef0f6fc67ef8a36ab80ebb25b0b0ab | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.60e-05 | 162 | 249 | 7 | d712bc31840ad1523e3dbf884acbb428a8995001 | |
| ToppCell | facs-Trachea-3m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_tracheal_l15|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.89e-05 | 164 | 249 | 7 | 5ca7b69684a8bb12dd0b45e7ad94e30d16ed01ce | |
| ToppCell | Adult-Immune-dendritic_cell|Adult / Lineage, Cell type, age group and donor | 4.04e-05 | 165 | 249 | 7 | 073f52698dac1fe4edd7410865f81b30e1c7196a | |
| ToppCell | 368C-Myeloid-Monocyte-CD16+_Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.36e-05 | 167 | 249 | 7 | dbd2b9f2f4ba7be5fdf8318094e6b078cb1d1c43 | |
| ToppCell | facs-GAT-Fat-18m-Myeloid-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.70e-05 | 169 | 249 | 7 | 7a7416fcbffcf57d19b477d9da091e04e3499524 | |
| ToppCell | facs-GAT-Fat-18m-Myeloid|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.70e-05 | 169 | 249 | 7 | 0e1a99cd77edcf32bcb513abd247b2b27409ac63 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.70e-05 | 169 | 249 | 7 | 4e1322cc5e1733e9fb19e08f739a30206f43cea8 | |
| ToppCell | facs-GAT-Fat-18m-Myeloid-myeloid_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.70e-05 | 169 | 249 | 7 | 9bbad31ef03078f5aa456f2e1b17b49c91545ff0 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.88e-05 | 170 | 249 | 7 | d7c9a604311974ff87ece43a0f8725a234d262f7 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-mLTo|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.88e-05 | 170 | 249 | 7 | 7653f1205d4e62abe7e31b1d76f9bbd665e45667 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.88e-05 | 170 | 249 | 7 | 0f215911b5880eeffeb43230f7eeaf55b612eaf2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.07e-05 | 171 | 249 | 7 | 55c7bf7211587fa08df13c0a4ff5b78a85d5439e | |
| ToppCell | 10x5'-Lung-Myeloid_Dendritic-DC1|Lung / Manually curated celltypes from each tissue | 5.26e-05 | 172 | 249 | 7 | 243b8bb01cbec5c1bf8802cbf8a6153356b4c384 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-05 | 172 | 249 | 7 | 35c20de4db47dbf31c857d23c7a25cd7f95c085c | |
| ToppCell | 5'-Adult-Distal_Rectal-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.45e-05 | 173 | 249 | 7 | 62abaaaf48cabd1423f17fb27c33b75ea88867f4 | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.45e-05 | 173 | 249 | 7 | 8bffd512a4e561e23cc04478e2ca6fd5d3771fe4 | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.45e-05 | 173 | 249 | 7 | 3e3c61468e703330788a10d850ef41a85680f86d | |
| ToppCell | 5'-Adult-Distal_Rectal-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.45e-05 | 173 | 249 | 7 | 09cd878c33534bd476d6a4880f5582076189da8c | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.66e-05 | 174 | 249 | 7 | 412ccc099028a372b9d953363984c2da54b2187f | |
| ToppCell | COVID-mDC1|COVID / Condition, Cell_class and T cell subcluster | 5.87e-05 | 175 | 249 | 7 | b9280444016e21c28131a61df65cc5c56d402412 | |
| ToppCell | 18-Distal-RBC|Distal / Age, Tissue, Lineage and Cell class | 5.87e-05 | 175 | 249 | 7 | cc476b4244442418b8f21721a82a36209b556b36 | |
| ToppCell | 18-Distal-RBC-RBC|Distal / Age, Tissue, Lineage and Cell class | 5.87e-05 | 175 | 249 | 7 | 7130b816e0c02309c161d8e9ad7cb4bc2469e251 | |
| ToppCell | COVID-mDC1-|COVID / Condition, Cell_class and T cell subcluster | 5.87e-05 | 175 | 249 | 7 | 83a95d6fc2ddf3ec53f05825bbc982fb8d2ccd15 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.08e-05 | 176 | 249 | 7 | cccf9201f6e2da7524b911a5961d3b227edab222 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.08e-05 | 176 | 249 | 7 | c0a084f7a8645262d61971f094689e02bf15b113 | |
| ToppCell | facs-Brain_Myeloid-Striatum-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.30e-05 | 177 | 249 | 7 | f6b9d91d46830d0d207b0abd4ee5a4942fd99774 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.30e-05 | 177 | 249 | 7 | 8abdf1d970b2f15e17e185f3e612dd5065c88757 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_pre_proliferating_SCP_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.30e-05 | 177 | 249 | 7 | 59726bfd98f656fdcedf448a7e2e76a9bfad8285 | |
| ToppCell | PBMC-Mild-cDC_11|Mild / Compartment, Disease Groups and Clusters | 6.30e-05 | 177 | 249 | 7 | 974305e4c0eff90134c4e58cf11b955d1eee0501 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.53e-05 | 178 | 249 | 7 | f332c7a96844abecf05ca057480fbea9296688a2 | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast-(8)_Activated_fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.76e-05 | 179 | 249 | 7 | 5787ffba96918db80256ced076a455a84ba01384 | |
| ToppCell | 390C-Lymphocytic-ILC-ILC-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.76e-05 | 179 | 249 | 7 | 3edcd1356e49b1f5514c585861999e079ca5e579 | |
| ToppCell | 390C-Lymphocytic-ILC-ILC-1|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.76e-05 | 179 | 249 | 7 | e7045e27f0eb88f552b31c04b56d78e5ccd7a36c | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-2|TCGA-Skin / Sample_Type by Project: Shred V9 | 7.25e-05 | 181 | 249 | 7 | 9d5b331cabc5524f0a9fd8b571e87be4c447c7d4 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Neuronal-Interneuron|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 7.32e-05 | 125 | 249 | 6 | eafc39072467e209c9fe3a4fa41cb09507a42e82 | |
| Drug | PNU-0230031 [267429-39-0]; Down 200; 1uM; PC3; HT_HG-U133A | PODNL1 INPP4A B4GALT1 FASN LMF2 RHBDD3 CLEC16A APC SEMA4G COL18A1 CSE1L CEP170B | 1.37e-06 | 194 | 245 | 12 | 4291_DN |
| Drug | Metaraminol bitartrate [33402-03-8]; Down 200; 8.6uM; MCF7; HT_HG-U133A | VWA8 PDK2 INPP4A INPP5B NAB2 B4GALT1 FECH NEDD4L SEMA7A ORC5 CSE1L SYMPK | 1.53e-06 | 196 | 245 | 12 | 2298_DN |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | STAG1 MYO10 DIPK1A BUB1B NIPBL DTL FRYL CHD7 MED13L TTLL4 WDFY3 | 3.08e-06 | 174 | 245 | 11 | 7530_DN |
| Drug | Amethopterin (R,S) [59-05-2]; Down 200; 8.8uM; MCF7; HT_HG-U133A | ACTR5 INPP5B SEMA4C BUB1B ZNF468 CLEC16A PSRC1 TDRD1 ORC5 WDFY3 CDK3 | 5.85e-06 | 186 | 245 | 11 | 5000_DN |
| Drug | troglitazone; Up 200; 10uM; MCF7; HT_HG-U133A_EA | ABCC3 PDK2 RPS6KA2 PHKB GLI3 C3 VAV1 ICOSLG TRIM2 SIDT2 CDK3 | 9.17e-06 | 195 | 245 | 11 | 1012_UP |
| Drug | Acenocoumarol [152-72-7]; Down 200; 11.4uM; MCF7; HT_HG-U133A | NR2F6 PDK2 INPP4A EXD3 LMF2 KIDINS220 ICOSLG TRIM2 NEDD4L SIDT2 CSE1L | 9.17e-06 | 195 | 245 | 11 | 2240_DN |
| Drug | Heliotrine [303-33-3]; Up 200; 12.8uM; MCF7; HT_HG-U133A | ABCC3 PDK2 RPS6KA2 KCNH2 C3 ICOSLG APC RAB6B GRPR AOC3 MED25 | 9.62e-06 | 196 | 245 | 11 | 4739_UP |
| Drug | Delcorine; Down 200; 8.4uM; MCF7; HT_HG-U133A | PDK2 INPP4A INPP5B RPS6KA2 HSPA12A LRP12 APC WDFY3 LONRF3 CDK3 SYMPK | 9.62e-06 | 196 | 245 | 11 | 3613_DN |
| Drug | ICI 182,780; Down 200; 1uM; ssMCF7; HG-U133A | PDK2 URB2 LONP1 LMF2 POP1 RHBDD3 NIPBL USP24 ADGRA2 CYFIP2 NUP93 | 9.62e-06 | 196 | 245 | 11 | 523_DN |
| Drug | Succinylsulfathiazole [116-43-8]; Up 200; 11.2uM; MCF7; HT_HG-U133A | ACTR5 NAB2 ABCC8 C3 ICOSLG LRP12 RAB6B GRPR CYFIP2 TTLL4 MED25 | 1.01e-05 | 197 | 245 | 11 | 2821_UP |
| Drug | Condelphine [7633-69-4]; Up 200; 8.8uM; PC3; HT_HG-U133A | INPP5B NAB2 MED14 B4GALT1 ALK FRYL GRM6 RAB6B SEMA4G MED25 CDK3 | 1.11e-05 | 199 | 245 | 11 | 6357_UP |
| Drug | aspirin, USP; Up 200; 100uM; MCF7; HT_HG-U133A | ABCC3 MYO10 RPS6KA2 ICOSLG TRIM2 TTC28 FSCN3 APC WDFY3 POLQ SYMPK | 1.11e-05 | 199 | 245 | 11 | 5201_UP |
| Drug | Orlistat; Down 200; 10uM; MCF7; HT_HG-U133A | ABCC3 RPS6KA2 NAB2 SPPL2B SPTBN5 ICOSLG NEDD4L SIDT2 AOC3 MED25 WDFY3 | 1.16e-05 | 200 | 245 | 11 | 6415_DN |
| Drug | Nyco | 3.56e-05 | 18 | 245 | 4 | CID000071618 | |
| Drug | LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 4.05e-05 | 189 | 245 | 10 | 1065_DN | |
| Drug | Yfrkd | 4.17e-05 | 7 | 245 | 3 | CID000129984 | |
| Drug | Dextromethorphan hydrobromide monohydrate [6700-34-1]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 4.63e-05 | 192 | 245 | 10 | 5401_DN | |
| Drug | Ethynylestradiol 3-methyl ether [72-33-3]; Up 200; 12.8uM; MCF7; HT_HG-U133A | PODNL1 INPP5B RPS6KA2 NAB2 SPTBN5 KIDINS220 ABCC8 LRP12 FSCN3 SNRNP200 | 5.28e-05 | 195 | 245 | 10 | 3346_UP |
| Drug | Bambuterol hydrochloride [81732-46-9]; Up 200; 10uM; MCF7; HT_HG-U133A | RPS6KA2 LMF2 KIDINS220 KCNH2 ALK DDX51 GRM6 GRPR OGDHL ACOXL | 5.28e-05 | 195 | 245 | 10 | 3199_UP |
| Drug | Tribenoside [10310-32-4]; Down 200; 8.4uM; PC3; HT_HG-U133A | MBTPS1 INPP4A DIPK1A RPS6KA2 SEMA4C NEDD4 RHBDD3 TRIM2 ORC5 WDFY3 | 5.51e-05 | 196 | 245 | 10 | 6328_DN |
| Drug | val-mCyd | 5.54e-05 | 20 | 245 | 4 | CID006918726 | |
| Drug | Diphenylpyraline hydrochloride [132-18-3]; Down 200; 12.6uM; MCF7; HT_HG-U133A | PODNL1 SPPL2B KCNH2 RHBDD3 NEDD4L SEMA7A APC SEMA4G TTLL4 CDK3 | 5.75e-05 | 197 | 245 | 10 | 6061_DN |
| Drug | Picrotoxinin [17617-45-7]; Up 200; 13.6uM; MCF7; HT_HG-U133A | DCAF1 INPP5B SPTBN5 LMF2 KIDINS220 FSCN3 RAB6B GRPR MED25 SNRNP200 | 6.00e-05 | 198 | 245 | 10 | 2816_UP |
| Drug | S(-)-terguride hydrogen maleate [37686-85-4]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 6.00e-05 | 198 | 245 | 10 | 6473_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 50uM; MCF7; HT_HG-U133A | MYO10 INPP4A MED14 B4GALT1 EXD3 GLI3 RHBDD3 CLEC16A CSE1L CDK3 | 6.00e-05 | 198 | 245 | 10 | 5582_DN |
| Drug | Mephenytoin [50-12-4]; Up 200; 18.4uM; MCF7; HT_HG-U133A | 6.00e-05 | 198 | 245 | 10 | 6275_UP | |
| Drug | Bufexamac [2438-72-4]; Up 200; 18uM; MCF7; HT_HG-U133A | SPTBN5 HSPA12A KCNH2 ICOSLG NEDD4L TTC28 RASGRF1 SEMA4G SIDT2 CDK3 | 6.00e-05 | 198 | 245 | 10 | 5515_UP |
| Drug | Sulfisoxazole [127-69-5]; Down 200; 15uM; MCF7; HT_HG-U133A | 6.00e-05 | 198 | 245 | 10 | 5622_DN | |
| Drug | ionomycin calcium salt; Down 200; 2uM; MCF7; HT_HG-U133A_EA | 6.00e-05 | 198 | 245 | 10 | 871_DN | |
| Drug | Dantrolene sodium salt [14663-23-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | SPTBN5 LMF2 TRANK1 RHBDD3 FSCN3 APC RAB6B ADGRA2 SEMA4G MED25 | 6.26e-05 | 199 | 245 | 10 | 2329_UP |
| Drug | Moroxidine hydrochloride [3160-91-6]; Up 200; 19.2uM; HL60; HG-U133A | PDK2 INPP4A F8 B4GALT1 CARD14 ICOSLG LRP12 FSCN3 MED13L CEP170B | 6.26e-05 | 199 | 245 | 10 | 2027_UP |
| Drug | AC1LAD6M | 6.62e-05 | 8 | 245 | 3 | CID000511663 | |
| Drug | 1hiv | 6.62e-05 | 8 | 245 | 3 | CID005479205 | |
| Drug | Chebi:36708 | 6.62e-05 | 8 | 245 | 3 | CID011966289 | |
| Drug | O4-[3-[(1S)-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxyphenyl)-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] O1-[3-[(1R)-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] (Z)-2-chlorobut-2-enedioate | 6.62e-05 | 8 | 245 | 3 | CID010011375 | |
| Drug | leucovorin | 8.43e-05 | 130 | 245 | 8 | CID000000143 | |
| Disease | Malignant neoplasm of breast | NR2F6 RPS6KA3 MED14 SIX4 BGN NEDD4 PHKB FASN LMF2 NDRG1 POP1 AP1M1 UTP20 HERC2 NIPBL ALK ZNF541 C1orf87 GRIK3 CUBN GRM6 TLL1 CD74 LONRF3 | 1.03e-05 | 1074 | 243 | 24 | C0006142 |
| Disease | level of dipeptidase 2 in blood serum | 6.75e-05 | 2 | 243 | 2 | OBA_2041349 | |
| Disease | transmembrane protein 119 measurement | 6.75e-05 | 2 | 243 | 2 | EFO_0803182 | |
| Disease | autosomal recessive nonsyndromic deafness 16 (implicated_via_orthology) | 6.75e-05 | 2 | 243 | 2 | DOID:0110471 (implicated_via_orthology) | |
| Disease | Intellectual Disability | STAG1 INPP4A KMT2E GTF3C3 FASN TRPM3 NXF5 DYNC1H1 RTTN APC NBEA MED13L COL18A1 | 9.55e-05 | 447 | 243 | 13 | C3714756 |
| Disease | Profound Mental Retardation | 1.60e-04 | 139 | 243 | 7 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 1.60e-04 | 139 | 243 | 7 | C0025363 | |
| Disease | Mental deficiency | 1.60e-04 | 139 | 243 | 7 | C0917816 | |
| Disease | importin subunit alpha-1 measurement | 2.02e-04 | 3 | 243 | 2 | EFO_0020467 | |
| Disease | Glioblastoma Multiforme | 3.23e-04 | 111 | 243 | 6 | C1621958 | |
| Disease | Coffin-Lowry syndrome (implicated_via_orthology) | 4.01e-04 | 4 | 243 | 2 | DOID:3783 (implicated_via_orthology) | |
| Disease | Congenital stationary night blindness | 4.01e-04 | 4 | 243 | 2 | cv:C0339535 | |
| Disease | Chediak-Higashi syndrome (implicated_via_orthology) | 4.01e-04 | 4 | 243 | 2 | DOID:2935 (implicated_via_orthology) | |
| Disease | ADP-ribosylation factor-like protein 11 measurement | 4.01e-04 | 4 | 243 | 2 | EFO_0801355 | |
| Disease | Liddle syndrome (implicated_via_orthology) | 4.01e-04 | 4 | 243 | 2 | DOID:0050477 (implicated_via_orthology) | |
| Disease | Glycogen phosphorylase kinase deficiency | 4.01e-04 | 4 | 243 | 2 | cv:C0268147 | |
| Disease | granulocyte percentage of myeloid white cells | 4.08e-04 | 268 | 243 | 9 | EFO_0007997 | |
| Disease | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement | 5.43e-04 | 170 | 243 | 7 | EFO_0000685, EFO_0007791, EFO_0007837 | |
| Disease | platelet component distribution width | ACTN1 CHKB RSU1 EXD3 TRANK1 TRPM3 POLK VAV1 PIF1 VPS18 RTTN LAMA5 CUBN COL18A1 SIDT2 ACOXL | 5.71e-04 | 755 | 243 | 16 | EFO_0007984 |
| Disease | unipolar depression, information processing speed, cognitive function measurement | 6.06e-04 | 47 | 243 | 4 | EFO_0003761, EFO_0004363, EFO_0008354 | |
| Disease | Primary Ciliary Dyskinesia | 6.06e-04 | 47 | 243 | 4 | C4551720 | |
| Disease | ras-related protein Rab-26 measurement | 6.64e-04 | 5 | 243 | 2 | EFO_0801989 | |
| Disease | level of N-sulphoglucosamine sulphohydrolase in blood serum | 6.64e-04 | 5 | 243 | 2 | OBA_2043486 | |
| Disease | bombesin receptor-activated protein C6orf89 measurement | 6.64e-04 | 5 | 243 | 2 | EFO_0801428 | |
| Disease | whole-brain volume | 6.64e-04 | 5 | 243 | 2 | EFO_0005089 | |
| Disease | muscular disease (implicated_via_orthology) | 6.64e-04 | 5 | 243 | 2 | DOID:0080000 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | ABCC3 ACACA ABCA13 LRRC4 ABCC8 GLI3 BUB1B DNAH8 MPO VPS18 APC GRIK3 CUBN CSE1L SNRNP200 | 7.78e-04 | 702 | 243 | 15 | C0009402 |
| Disease | platelet crit | STAG1 DIPK1A ANKRD9 ACTN1 TYK2 PHKB LRRN2 HFM1 PIF1 MOV10 FLT3 TTC28 C6orf89 RTTN DTL LAMA5 CUBN UBASH3B | 9.83e-04 | 952 | 243 | 18 | EFO_0007985 |
| Disease | Paratuberculosis | 9.91e-04 | 6 | 243 | 2 | C0030524 | |
| Disease | Pleocytosis | 9.91e-04 | 6 | 243 | 2 | C0151857 | |
| Disease | congenital muscular dystrophy (implicated_via_orthology) | 9.91e-04 | 6 | 243 | 2 | DOID:0050557 (implicated_via_orthology) | |
| Disease | Inflammatory Myofibroblastic Tumor | 9.91e-04 | 6 | 243 | 2 | C0334121 | |
| Disease | primary ciliary dyskinesia (is_implicated_in) | 9.91e-04 | 6 | 243 | 2 | DOID:9562 (is_implicated_in) | |
| Disease | Leukocytosis | 9.91e-04 | 6 | 243 | 2 | C0023518 | |
| Disease | obsolete_Fms-related tyrosine kinase 3 ligand measurement | 1.38e-03 | 7 | 243 | 2 | EFO_0010594 | |
| Disease | Polysyndactyly | 1.38e-03 | 7 | 243 | 2 | C0265553 | |
| Disease | retinitis pigmentosa (implicated_via_orthology) | 1.39e-03 | 27 | 243 | 3 | DOID:10584 (implicated_via_orthology) | |
| Disease | multiple sclerosis | VWA8 TSPOAP1 DIPK1A CNOT6 TYK2 CLEC16A MPO TRIM2 TTC28 RASGRF1 IFNGR2 TLL1 UBASH3B | 1.39e-03 | 594 | 243 | 13 | MONDO_0005301 |
| Disease | rheumatoid arthritis, ACPA-positive rheumatoid arthritis, rheumatoid factor seropositivity measurement | 1.83e-03 | 63 | 243 | 4 | EFO_0000685, EFO_0007791, EFO_0009459 | |
| Disease | rheumatoid arthritis, COVID-19 | 1.94e-03 | 64 | 243 | 4 | EFO_0000685, MONDO_0100096 | |
| Disease | Disorder of eye | 1.96e-03 | 212 | 243 | 7 | C0015397 | |
| Disease | social communication impairment | 2.29e-03 | 32 | 243 | 3 | EFO_0005427 | |
| Disease | comparative body size at age 10, self-reported | ZNF536 CADM2 FOCAD FAM120A DPEP2 ALK MOV10 SEC16B FLT3 MED13L | 2.69e-03 | 420 | 243 | 10 | EFO_0009819 |
| Disease | dipeptidase 2 measurement | 2.91e-03 | 10 | 243 | 2 | EFO_0801528 | |
| Disease | cystic kidney disease (implicated_via_orthology) | 2.91e-03 | 10 | 243 | 2 | DOID:2975 (implicated_via_orthology) | |
| Disease | alpha wave measurement, electroencephalogram measurement | 2.91e-03 | 10 | 243 | 2 | EFO_0004357, EFO_0006870 | |
| Disease | Kartagener Syndrome | 2.97e-03 | 35 | 243 | 3 | C0022521 | |
| Disease | Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus | 2.97e-03 | 35 | 243 | 3 | C4551906 | |
| Disease | Polynesian Bronchiectasis | 2.97e-03 | 35 | 243 | 3 | C4317124 | |
| Disease | monocyte percentage of leukocytes | TSPOAP1 AP1M1 C3 MPO SLC25A24 ZYG11A FLT3 CHD7 MED13L MEI1 NLRP6 WDFY3 UBASH3B ACOXL | 3.15e-03 | 731 | 243 | 14 | EFO_0007989 |
| Disease | Primary ciliary dyskinesia | 3.22e-03 | 36 | 243 | 3 | cv:C0008780 | |
| Disease | Retinal Detachment | 3.54e-03 | 11 | 243 | 2 | C0035305 | |
| Disease | Paranoia | 3.54e-03 | 11 | 243 | 2 | C1456784 | |
| Disease | urinary albumin to creatinine ratio | 3.77e-03 | 179 | 243 | 6 | EFO_0007778 | |
| Disease | hip bone mineral density | 3.96e-03 | 126 | 243 | 5 | EFO_0007702 | |
| Disease | Night blindness, congenital stationary, type 1 | 4.22e-03 | 12 | 243 | 2 | C3501847 | |
| Disease | Night Blindness, Congenital Stationary, Type 1A | 4.22e-03 | 12 | 243 | 2 | C3495587 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B (disorder) | 4.22e-03 | 12 | 243 | 2 | C1864877 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B | 4.22e-03 | 12 | 243 | 2 | C1850362 | |
| Disease | X-Linked Csnb | 4.22e-03 | 12 | 243 | 2 | C3711543 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A | 4.22e-03 | 12 | 243 | 2 | C1848172 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 4.23e-03 | 128 | 243 | 5 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 4.23e-03 | 128 | 243 | 5 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 4.23e-03 | 128 | 243 | 5 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 4.23e-03 | 128 | 243 | 5 | C1306837 | |
| Disease | Renal Cell Carcinoma | 4.23e-03 | 128 | 243 | 5 | C0007134 | |
| Disease | Cone-rod synaptic disorder, congenital nonprogressive | 4.96e-03 | 13 | 243 | 2 | C4041558 | |
| Disease | rheumatoid arthritis | STAG1 NEDD4 TYK2 ICOSLG FLT3 ANKRD50 WDFY4 IFNGR2 CEP170B ACOXL | 5.23e-03 | 462 | 243 | 10 | EFO_0000685 |
| Disease | age-related hearing impairment | 5.65e-03 | 324 | 243 | 8 | EFO_0005782 | |
| Disease | Diabetes, Autoimmune | 5.70e-03 | 44 | 243 | 3 | C0205734 | |
| Disease | Brittle diabetes | 5.70e-03 | 44 | 243 | 3 | C0342302 | |
| Disease | Diabetes Mellitus, Sudden-Onset | 5.70e-03 | 44 | 243 | 3 | C4554117 | |
| Disease | Diabetes Mellitus, Ketosis-Prone | 5.70e-03 | 44 | 243 | 3 | C3837958 | |
| Disease | inositol measurement | 5.76e-03 | 14 | 243 | 2 | EFO_0010504 | |
| Disease | Diabetes Mellitus, Insulin-Dependent | 6.07e-03 | 45 | 243 | 3 | C0011854 | |
| Disease | ovarian serous carcinoma | 6.45e-03 | 46 | 243 | 3 | EFO_1001516 | |
| Disease | acute graft vs. host disease, donor genotype effect measurement | 6.61e-03 | 15 | 243 | 2 | EFO_0004599, EFO_0007892 | |
| Disease | Rhabdomyosarcoma | 6.61e-03 | 15 | 243 | 2 | C0035412 | |
| Disease | post-traumatic stress disorder | 6.74e-03 | 202 | 243 | 6 | EFO_0001358 | |
| Disease | mean reticulocyte volume | DIPK1A ANKRD9 URB2 CNOT6 LONP1 DPEP2 ZYG11A FLT3 C6orf89 NLRX1 RTTN RAB6B ZNF888 ACOXL | 6.79e-03 | 799 | 243 | 14 | EFO_0010701 |
| Disease | cutaneous Leishmaniasis | 7.51e-03 | 16 | 243 | 2 | EFO_0005046 | |
| Disease | phosphatidylcholine 38:6 measurement | 7.51e-03 | 16 | 243 | 2 | EFO_0010388 | |
| Disease | Cannabis use | 7.51e-03 | 16 | 243 | 2 | EFO_0007585 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 7.75e-03 | 148 | 243 | 5 | C0279702 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LRMISSTFLNLPFQG | 811 | Q9BXT4 | |
| VQFLRASLQPGMRDI | 1486 | Q14146 | |
| AERMANPRSFLLLGD | 716 | Q7Z4L5 | |
| PLRQGRIMSTLQGAL | 31 | O60566 | |
| TRDVAFLLRQEGRPM | 146 | Q6UWY0 | |
| LVFRGMSISRPNAVV | 321 | P15291 | |
| EFARIMSIVDPNRLG | 791 | P12814 | |
| LGNVAVLMELSAFPR | 746 | Q96PE1 | |
| RVFLSGMPELRLGLN | 201 | Q9BXS5 | |
| FPFTSSMLRSLRLQQ | 6 | Q96NS5 | |
| RPGETLNVNFLLRMD | 466 | P01024 | |
| FLRGNPRVTRLLSEM | 381 | Q96SM3 | |
| TLASNERIALTPFMR | 2281 | Q96DT5 | |
| FRTLLEMQPRNALSG | 4226 | Q96DT5 | |
| GIQLIRDVFNSLMPV | 1631 | Q86UQ4 | |
| LELNRMRNFDLTAIP | 1381 | Q13085 | |
| NFIMLREIRDIPGTL | 316 | Q9ULJ7 | |
| LLEMRPFRSSFQVQL | 511 | Q9H9F9 | |
| ERIRMENILSGNPLL | 156 | Q9P013 | |
| MLFNSVLRQPQLGVL | 1 | Q9NZJ0 | |
| QRMALLQEFASRPLG | 626 | Q9Y4F5 | |
| VMFAILAERSLGPQL | 121 | Q9Y259 | |
| QMELLQAGLSRTPTR | 2481 | Q9P2D1 | |
| MQTAGALFISPALIR | 1 | P05496 | |
| ARFNAMLAALTPSRL | 226 | Q9NUZ1 | |
| RRFRSGENMLLEPAL | 526 | Q8N0U7 | |
| QMIFNRELPQASGLL | 181 | Q16853 | |
| FRQQSSLGLCIPRLM | 31 | Q2M243 | |
| RSQARTLITFAGMIP | 786 | Q8N1F7 | |
| RAVPASLISQLFFMR | 361 | P10588 | |
| LFRRVASALPGMENV | 166 | Q9NRW1 | |
| MSFGDRPNLELLRAL | 116 | O95153 | |
| QRLFALVLRLPGTMS | 166 | Q9UL03 | |
| ALPREIQSGMLLRVQ | 781 | Q96PE3 | |
| QDPILFSGTLRMNLD | 1371 | O15438 | |
| AQDMLDGLQRLRSQP | 16 | Q0D2K2 | |
| TLRMELPQRDVFSGS | 471 | O60568 | |
| LRSLQDLGPEMRQAL | 1621 | O60840 | |
| QELLPIFMQLGSREL | 341 | Q9Y4B6 | |
| RALILLGQMGRISPF | 36 | P01566 | |
| IVSRGRMQLFSLNPR | 66 | Q9Y5G7 | |
| RMQLFSLNPRNGSLV | 71 | Q9Y5G7 | |
| MAEGSRIPQARALLQ | 1 | Q96FN9 | |
| FSDISPQTMRRLLNI | 931 | Q9ULH0 | |
| GSRRQAMPRDSLALQ | 1391 | P10071 | |
| RSLLQILRQDMTPGG | 526 | Q7Z4F1 | |
| AVRSQLGFTSVRLPM | 581 | Q9Y561 | |
| DDRTVLVGQRLPLMA | 596 | Q71F56 | |
| RLLQFVTGTSRVPMN | 1241 | P46934 | |
| LIASARRLPGVNMFE | 446 | Q14703 | |
| RNTLTNIAMRPGLEG | 176 | P33992 | |
| ARAMALPRTLGELQL | 31 | Q15742 | |
| VNISPGRRFMIDLLV | 921 | O95714 | |
| LLELPRGDLRTFVNM | 226 | Q8NI38 | |
| QMLSRLLVGLVQSRP | 251 | Q5MY95 | |
| FVLRRGRMSGNPDVL | 31 | Q8WWW8 | |
| LSPEAQSLLRMLFKR | 291 | P51812 | |
| RTQPGLFAEMFRLRI | 906 | P46020 | |
| DMNFRPLANLRSLVL | 206 | O75325 | |
| VQRLRGLMNDIAAFP | 111 | Q86YB7 | |
| FIPIRRSGDVSQELM | 1901 | Q5SZK8 | |
| RALILLAQMGRISPF | 36 | P01568 | |
| LEITFNLRDTNMIPG | 856 | Q12809 | |
| NIIVATPGRLEDMFR | 136 | Q8NHQ9 | |
| LAGPRMTVTNLLSRN | 456 | P29536 | |
| LDLQNLRFDPDLMGR | 121 | Q9H1B4 | |
| MSQLRLLPSRLGVQA | 1 | Q9ULD0 | |
| RLFEQVMRIGLDLPA | 571 | P05164 | |
| GLQGRRVINLPLDSM | 131 | Q96PD5 | |
| RMIENGSLSFLPTLR | 266 | P21810 | |
| LTRFALNNPEMVEGL | 146 | Q92597 | |
| EEFQRMPLARSSRGL | 596 | P39060 | |
| FDGTRARLLPEAIMN | 116 | Q8WU58 | |
| LNGIRDMLANIFLPA | 51 | Q96JB1 | |
| TINPERMNIGLRVFL | 441 | O94915 | |
| MSFQAPRRLLELAGQ | 1 | Q5VWM3 | |
| NMSQLLNSGVPRRIL | 796 | Q9H0H0 | |
| RALILLAQMGRISPF | 36 | P01567 | |
| AVDPSILARLDMQRG | 1801 | Q6KC79 | |
| RSMFLRGEEILTPLN | 376 | Q9HD67 | |
| AAPGVDLSRILNEMR | 276 | P08779 | |
| MLTLGPFRNSNLTEL | 976 | Q8IZD2 | |
| AFNRVPSLMRLDLGE | 166 | Q9HBW1 | |
| VTALLSLAMGRPVRQ | 861 | P36776 | |
| QLLTTLGPLFRNSRM | 456 | Q71SY5 | |
| MVFTPESGLQLRLNE | 866 | P00451 | |
| NLDPRGIQLSALFMS | 761 | Q9NZB2 | |
| VPARREIQTLMQFGD | 636 | O43301 | |
| QRLNLPVMGATRSNL | 336 | Q6PGN9 | |
| LDGARTPLLQRMQTF | 2461 | O15230 | |
| SSLRQLNLAGVRMTP | 696 | Q86UT6 | |
| FLELTMGRRIQFPIE | 651 | Q96F07 | |
| RFPIILVMRGRENDS | 116 | A0A2R8YFL7 | |
| LPSGQLMGLFNRIIR | 886 | Q9H0A0 | |
| TFLRQELPVRLANIM | 51 | Q15119 | |
| NMPFVGLRLELSNLE | 651 | O60244 | |
| PLRMSQVRSLVIGLQ | 1096 | Q5TIA1 | |
| TPMLLRALAQAARAG | 6 | O00217 | |
| MGRNNLTRPSEFILL | 51 | Q8NH94 | |
| MLRGDFSLRLFNVTP | 91 | O75144 | |
| TDILQMIGRAGRPQF | 646 | A2PYH4 | |
| RSLDLAGNQLTRLPM | 411 | Q6PEZ8 | |
| DLNRMRSELLVPGSQ | 571 | Q99575 | |
| MLQPETFGDLLRLER | 136 | A1KZ92 | |
| GSPMALLLAARQRAQ | 836 | Q5T0Z8 | |
| QLFRIFRMLGTPSED | 211 | Q00526 | |
| PQRLDRLSGLADQMV | 196 | O95400 | |
| QPRMATERGNLVFLT | 41 | O60494 | |
| NRRPFSREMDLGLLS | 971 | P36888 | |
| SMRGLNPKILFSSRE | 726 | O14976 | |
| MIALNRSLPDVRLEG | 91 | Q10472 | |
| GPRMSQNLLRQADLD | 116 | Q9P2D7 | |
| RLMETPNARGIIIFA | 266 | O15303 | |
| PARRILSQVTMLAFQ | 561 | Q9BXL6 | |
| TDNLLMLNGRSSLFP | 281 | Q7Z5Q1 | |
| RFLRMLTEAGAPELQ | 616 | Q8N8A6 | |
| MPRTEFARLNGDVRL | 141 | Q8NDZ4 | |
| MDQLRRLPSGLDSVL | 391 | O75417 | |
| MRNVPNLFISSLALG | 71 | P30550 | |
| STELNEEPLMRFGRL | 2801 | P12111 | |
| VVLAMSPIGDAFRNR | 2471 | Q8WXX0 | |
| RFLGIAPNSLLMANV | 356 | Q9NQT6 | |
| PDRMVVSGRELNILF | 271 | Q8N3J6 | |
| RAMQVLVTAISPGRF | 281 | Q96BM1 | |
| QRDIVGFPNGSMLLR | 96 | Q7Z692 | |
| SMLRRNTPLLGQALT | 166 | Q96H22 | |
| QFLDGPASMRIRELN | 471 | Q8NEE6 | |
| MAPSFTARIQLFLLR | 1 | Q6GMR7 | |
| GSRFQAEIPLMRDRA | 726 | Q6PJG2 | |
| PMDFNVTLRLRAELG | 106 | P38484 | |
| LSLVFQLPFGSQTRM | 106 | P32019 | |
| LLIQAFRPDRLLAMA | 3991 | Q14204 | |
| GLQEQARALMRDFPL | 71 | Q9H4A9 | |
| MDIPISSRDFRGLQL | 1 | A6PVL3 | |
| MRDLRAQVTSGLLPF | 1 | Q8WYP5 | |
| ALLPNMISRRTGQIV | 161 | A6NNS2 | |
| RDLISNNEQLPMLGR | 21 | P04233 | |
| RGRAQALMRSFPLVD | 81 | Q9H4B8 | |
| RLFLDRDLMTLPIQN | 91 | P22830 | |
| LNRSQMLRELFPVFT | 236 | Q6UWU4 | |
| TVQPMALLLFRSNRD | 516 | P82279 | |
| MERLQAAPRSESGLL | 301 | Q13003 | |
| LMRLNSVQSSERPLF | 2231 | P49327 | |
| MAPRRLLLVGEGNFS | 1 | Q9BRP7 | |
| ELFIPSGFRRSMDQL | 246 | Q5T7M9 | |
| AARARPLVMTLNSLG | 226 | Q96S37 | |
| RIPRFMLLESGGLQI | 526 | Q7Z5N4 | |
| FLVINSLGRRPAQMA | 386 | Q4U2R8 | |
| SLGRRPAQMAALLLA | 391 | Q4U2R8 | |
| LSSNELVLRPRGFFM | 851 | Q6ZTR5 | |
| IRSLPAELGNMVSLR | 86 | Q9ULM6 | |
| RALILLAQMGRISPF | 36 | P01571 | |
| QMLAQPQRLLFILDG | 266 | P59044 | |
| DGLTFPRQLMEVSQL | 796 | Q8N137 | |
| LLSPLMRLNFGEEIQ | 1411 | Q5VW36 | |
| RQISRPSAAGINLMI | 1136 | Q08211 | |
| QGAALRASRAPMLLV | 21 | Q96QI5 | |
| IRGSRFNPILDMLAA | 626 | Q93100 | |
| LNLGMNRLNTLPRGF | 91 | Q15404 | |
| PSLERTLRGMANLTA | 1261 | Q86VV8 | |
| RSLQGLRVLDFDPMA | 586 | Q9H611 | |
| RENILPSEQMGFLIS | 526 | Q4G112 | |
| TRMAIVLRFLAGTQP | 1036 | O75691 | |
| VSFQVPLILRGMFQR | 91 | Q8NBJ9 | |
| LMFLGLQRRQAPTGL | 421 | Q9BX59 | |
| DMNTLSLPLNIRRGG | 31 | Q9ULS5 | |
| RNTFSRGMFLDTILP | 301 | O43897 | |
| SIMGNVLRFLPAFVR | 116 | Q9NXC2 | |
| MAGSRLPRQLFLQGV | 1 | Q9BU23 | |
| RQLLPMLLQGTSIFT | 301 | Q9HCE1 | |
| LMVTPAGRNAFREFL | 266 | O76081 | |
| MSFQAPRRLLELAGQ | 1 | Q5SWL8 | |
| RDMEANLLPGFLRLQ | 131 | O43913 | |
| SMIPAFDQRNGIRVI | 736 | Q8NFP9 | |
| LPRAAVRILSNMTFL | 421 | Q9H2Y9 | |
| ERPFALGMQFVLLRT | 681 | Q9H2Y9 | |
| GLERSLVFSQLMPVN | 571 | Q9UIU6 | |
| MLFPEAQRLESTGRL | 266 | Q8WVM0 | |
| FALSVPTLGMEQGRR | 106 | Q9BR26 | |
| LNNFLGTEPIILRNM | 181 | Q9C0C4 | |
| LLQAMERPGRSQAFL | 56 | O15130 | |
| DLPRSRINAGMLAQF | 6 | P35244 | |
| ILVNNFLRPLRMAAS | 261 | Q13972 | |
| LATDPRFAQLLEMLR | 451 | P51688 | |
| MLALLGQEQTPRDFL | 116 | Q7RTU9 | |
| LRFLQELSEPQLRAM | 1006 | Q7RTU9 | |
| SMTQLLGDPQAGIRR | 1196 | Q9NRP7 | |
| ARDFPDSLPAMRQLL | 331 | Q9NRC6 | |
| RILNLLSPSDGERFM | 276 | Q9Y5Q9 | |
| LNRIILAPMRFFETT | 1101 | Q09428 | |
| RSKEMPRGSFLLLNT | 311 | Q9UM73 | |
| VPMRTVGLENRLNSF | 2711 | P25054 | |
| FLLRNVMRISPDQGQ | 516 | Q00610 | |
| FMLRSLSLQLRGEPE | 671 | Q2KHT3 | |
| LRSLPAELGNMVSLR | 91 | Q96LI5 | |
| MALPQGLLTFRDVAI | 1 | Q8N782 | |
| SLRLQQLERMGFPTE | 326 | Q9Y3P4 | |
| ARAAVSELMQLFPRG | 146 | P49842 | |
| APVLALAMEQRRGQL | 701 | Q96KV7 | |
| LERLFTMRGPNNATL | 526 | P55060 | |
| PINESFISMVIGRLR | 216 | Q12768 | |
| VRMEPFTQIFLRLQG | 2801 | Q8IZQ1 | |
| LVALPSRLRRMNGNS | 781 | Q9NTN9 | |
| ANLPLRSGRNMEVSL | 106 | Q9HCQ7 | |
| ELPLGFSRMNRFRQS | 151 | Q9C0H9 | |
| MILRLQDQPFRSDGR | 981 | Q9HCF6 | |
| LEQLRGRTTMALDLP | 986 | A6NE52 | |
| NNGRFTLRDLLMVPM | 316 | P15498 | |
| EMGSRLDARQLIPAL | 616 | Q9P253 | |
| VNRLSRILMELDGPN | 561 | Q07617 | |
| FVALALMQRGQPALL | 461 | Q8TCT7 | |
| LRLMGVRISSFPNEE | 506 | Q9UBT6 | |
| TFIQPNMRLRQLGVA | 356 | Q06203 | |
| RMSFIAPNLSIIIGA | 211 | Q8WWY3 | |
| ISSRDNAMPVFLLRN | 1321 | Q6ZS81 | |
| GQLLSERLMRPNGVQ | 306 | Q9C0B7 | |
| RGSLFTLFLNNPLMA | 471 | Q8N9R8 | |
| IQPFRRAAAIQTMSL | 456 | O75326 | |
| PRLLLTMDQRRFSGL | 131 | Q6UXR4 | |
| GRNSPNGNLIRMLVL | 456 | Q8WVM7 | |
| LTELLQFEPTRRLGM | 511 | Q9Y6S9 | |
| ENMLLPAGLRQRDQT | 41 | Q9NZQ9 | |
| MALPQGLLTFRDVAI | 1 | Q6ZN06 | |
| RMDLNPSFLGIALRS | 91 | Q8IY26 | |
| NDPLQTLFQLMSGRI | 496 | Q96JE7 | |
| ALGSLANIARQRPMF | 256 | Q92797 | |
| QQPALLRDRSLGSAM | 736 | O15090 | |
| PMERRLVEQLFSSGA | 1626 | O75643 | |
| MALPQGLLTFRDVAI | 1 | P0CJ79 | |
| TDPTGFLRMVRRNNL | 1341 | Q96AY4 | |
| GADEQRRSVPFQMLL | 91 | Q3LFD5 | |
| QLARFLLVGQTMPTL | 1241 | Q9UPU5 | |
| NVARLLRMALNSGLT | 121 | Q6ZRF7 | |
| MALPQGLLTFRDVAI | 1 | P17035 | |
| MALPQGLLTFRDVAI | 1 | Q7L2R6 | |
| MLALLGQEQTPRDFL | 116 | A6NGW2 | |
| LRFLQELSEPQLRAM | 1006 | A6NGW2 | |
| GADEQRRSVPFQMLL | 91 | Q9UMW8 | |
| ALRQLTEMGFPENRA | 196 | Q9BSL1 | |
| LDVLLSMGFPRARAQ | 41 | Q8TF42 | |
| FFITNLMDVLQRTPG | 81 | Q9C040 | |
| MLLRFGADPTLLDRQ | 266 | O15050 | |
| LQRTLPAGRSFVAMD | 1871 | A3KMH1 | |
| QMIRDLLNLAGFVLP | 926 | Q14679 | |
| FIRLRPAMQFVGLLA | 306 | Q6WRX3 | |
| MALPQGLLTFRDVAI | 1 | Q5VIY5 | |
| LQAAMANPRALQALR | 511 | Q9H347 | |
| GSPQLNMVGLFRRII | 421 | Q6NUK1 | |
| LINTEMRPFSQGILI | 406 | Q08AF3 | |
| VLIPEQQFTLGRMLG | 511 | Q06418 | |
| QSRLRSPMFLVDCLL | 971 | Q9H0D2 | |
| SQAPDGMQSLRLRKF | 491 | P29597 | |
| LEPVLSSNLAQRRGM | 711 | Q15349 | |
| LESRAQLPFLAMRSL | 726 | Q496Y0 | |
| AGFPDLQRRLLVLMD | 191 | Q8N9H8 | |
| PGMTLSLAERLFFQV | 276 | Q8N9F0 | |
| IRLLQFVTGTSRVPM | 896 | Q96PU5 |